Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

[What's wrong with grades?].

Landmark K.

Tidsskr Nor Laegeforen. 2014 Feb 25;134(4):385. doi: 10.4045/tidsskr.14.0098. Norwegian. No abstract available.

2.

[Fish and omega-3 fatty acids and heart failure].

Landmark K, Alm CS.

Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2281-4. doi: 10.4045/tidsskr.11.1302. Review. Norwegian.

3.

[Does omega-3 fatty acids affect cardiovascular disease?].

Landmark K, Alm CS.

Tidsskr Nor Laegeforen. 2013 Feb 5;133(3):269. doi: 10.4045/tidsskr.12.1464. Norwegian. No abstract available.

4.

[Patterns in the prescription of antihypertensive drugs in Norway, 1975-2010].

Blix HS, Landmark K, Selmer R, Reikvam A.

Tidsskr Nor Laegeforen. 2012 May 29;132(10):1224-8. doi: 10.4045/tidsskr.11.0984. Norwegian.

5.

Choice of initial antihypertensive drugs and persistence of drug use--a 4-year follow-up of 78,453 incident users.

Selmer R, Blix HS, Landmark K, Reikvam A.

Eur J Clin Pharmacol. 2012 Oct;68(10):1435-42. doi: 10.1007/s00228-012-1261-2. Epub 2012 Mar 18.

PMID:
22427171
6.

Strain-promoted "click" chemistry for terminal labeling of DNA.

Marks IS, Kang JS, Jones BT, Landmark KJ, Cleland AJ, Taton TA.

Bioconjug Chem. 2011 Jul 20;22(7):1259-63. doi: 10.1021/bc1003668. Epub 2011 Jun 2.

7.

RAS inhibitors and size of infarct.

Landmark K, Aursnes I, Kvan E, Reikvam A.

Tidsskr Nor Laegeforen. 2011 Mar 4;131(5):441-2. doi: 10.4045/tidsskr.11.0095. English, Norwegian. No abstract available.

8.

[Calcium antagonists in treatment of hypertension].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2009 Dec 3;129(23):2488-9. doi: 10.4045/tidsskr.09.0299. Review. Norwegian.

9.

[Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2009 Sep 10;129(17):1740-4. doi: 10.4045/tidsskr.08.0401. Review. Norwegian.

10.

[Important witnesses in Gaza].

Landmark K.

Tidsskr Nor Laegeforen. 2009 Mar 12;129(6):542. doi: 10.4045/tidsskr.09.0193. Norwegian. No abstract available.

11.

Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers.

Landmark KJ, Dimaggio S, Ward J, Kelly C, Vogt S, Hong S, Kotlyar A, Myc A, Thomas TP, Penner-Hahn JE, Baker JR, Holl MM, Orr BG.

ACS Nano. 2008 Apr;2(4):773-83. doi: 10.1021/nn800034w.

PMID:
19206610
12.

[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2008 Jan 31;128(3):294-7. Review. Norwegian.

13.

Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity.

Landmark KE, Johansen PW, Johnson JA, Johansen B, Uran S, Skotland T.

Ultrasound Med Biol. 2008 Mar;34(3):494-501. Epub 2007 Dec 21.

PMID:
18096304
14.

[Rivastigmine against dementia in Parkinson disease?].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2007 Nov 15;127(22):2973; author reply 2973-4. Norwegian. No abstract available.

15.
16.

[Omega-3-fatty acids still beneficial in cardiovascular disease].

Landmark K, Aursnes I, Reikvam A, Alm CS.

Tidsskr Nor Laegeforen. 2007 Jan 18;127(2):202-3. Norwegian. No abstract available.

17.

[Alpha-linolenic acid, cardiovascular disease and sudden death].

Landmark K, Alm CS.

Tidsskr Nor Laegeforen. 2006 Nov 2;126(21):2792-4. Review. Norwegian.

18.

[Can fish oils protect against development of atrial fibrillation?].

Landmark K, Alm CS.

Tidsskr Nor Laegeforen. 2006 Jun 8;126(12):1621. Norwegian. No abstract available.

19.

[Could intake of vitamins C and E inhibit development of Alzheimer dementia?].

Landmark K.

Tidsskr Nor Laegeforen. 2006 Jan 12;126(2):159-61. Review. Norwegian.

20.

Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.

Toft KG, Hustvedt SO, Hals PA, Oulie I, Uran S, Landmark K, Normann PT, Skotland T.

Ultrasound Med Biol. 2006 Jan;32(1):107-14.

PMID:
16364802
21.

Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.

Kvan E, Pettersen KI, Landmark K, Reikvam A; INPHARM study investigators.

Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):261-7.

PMID:
16315337
22.
23.

[Statins and prevention of stroke].

Reikvam A, Landmark K.

Tidsskr Nor Laegeforen. 2005 May 19;125(10):1385-6; author reply 1386. Norwegian. No abstract available.

24.

[Wrong about thiazides].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2005 Apr 21;125(8):1045-6; author reply 1046. Norwegian. No abstract available.

25.

[Misleading information about thiazides].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2005 Feb 3;125(3):328; author reply 328. Norwegian. No abstract available.

26.

[Diuretics, hypertension and coronary heart disease].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2005 Feb 3;125(3):325-6. Norwegian. No abstract available.

27.

[Do vitamins C and E protect against the development of carotid stenosis and cardiovascular disease?].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2005 Jan 20;125(2):159-62. Review. Norwegian.

28.

[ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2005 Jan 6;125(1):38-40. Review. Norwegian.

29.

[Thiazides (only) and hard endpoints].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2004 Nov 18;124(22):2942; author reply 2942-3. Norwegian. No abstract available.

30.

[Can hydrochlorothiazide and chlorthalidone be compared in the treatment of hypertension?].

Os I, Landmark K, Toft I.

Tidsskr Nor Laegeforen. 2004 Mar 18;124(6):829. Norwegian. No abstract available.

31.

[Mercury, fish, fish oil and the risk of cardiovascular disease].

Landmark K, Aursnes I.

Tidsskr Nor Laegeforen. 2004 Jan 22;124(2):198-200. Review. Norwegian.

32.

[Nitrate therapy during and after acute myocardial infarction].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3377-80. Review. Norwegian.

PMID:
14713972
33.

Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function.

Reikvam A, Kvan E, Landmark K, Aursnes I; INPHARM Study Investigators.

Scand Cardiovasc J. 2003 Jun;37(3):130-4.

PMID:
12881153
34.

[Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].

Reikvam A, Madsen S, Landmark K.

Tidsskr Nor Laegeforen. 2003 Jun 26;123(13-14):1838-40. Review. Norwegian.

PMID:
12830258
35.

[Magnesium in pre-eclampsia/eclampsia].

Landmark K.

Tidsskr Nor Laegeforen. 2003 Apr 10;123(8):1084-5. Review. Norwegian. No abstract available.

PMID:
12760230
36.

Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortality.

Landmark K, Aursnes I, Kvan E, Reikvam A; Inpharm Study Investigators.

Blood Press. 2003;12(1):40-5.

PMID:
12699134
37.

[Anticholesteremic agents and omega-3 fatty acids].

Landmark K, Aursnes I.

Tidsskr Nor Laegeforen. 2003 Jan 23;123(2):212; author reply 212. Norwegian. No abstract available.

38.

[Meta-analyses, magnesium and acute myocardial infarction].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2001 Jan 10;121(1):97-8. Norwegian. No abstract available.

39.

[Hypokalemia can accelerate the development of cerebrovascular and cardiovascular disease].

Landmark K.

Tidsskr Nor Laegeforen. 2002 Feb 20;122(5):499-501. Review. Norwegian.

PMID:
11961979
40.

[Do nitrates reduce the risk of drug induced hemorrhage of the upper gastrointestinal tract?].

Landmark K.

Tidsskr Nor Laegeforen. 2001 Sep 10;121(21):2522-3. Norwegian. No abstract available.

41.

[Low-dosage acetylsalicylic acid as primary prevention against cardiovascular disease].

Landmark K.

Tidsskr Nor Laegeforen. 2001 Jun 20;121(16):1937-9. Norwegian. No abstract available.

42.

[Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].

Landmark K, Aursnes I.

Tidsskr Nor Laegeforen. 2001 Jun 20;121(16):1923-6. Review. Norwegian.

PMID:
11488184
43.
44.

[Smoking and coronary heart disease].

Landmark K.

Tidsskr Nor Laegeforen. 2001 May 30;121(14):1710-2. Review. Norwegian.

PMID:
11446015
45.

[Are the newer antihypertensive agents better and more effective than diuretics?].

Landmark K.

Tidsskr Nor Laegeforen. 2001 Feb 28;121(6):701-5. Review. Norwegian.

PMID:
11293353
46.

[Nutrition, dietary supplementation and coronary heart disease].

Landmark K, Reikvam A.

Tidsskr Nor Laegeforen. 2000 Sep 20;120(22):2648-53. Review. Norwegian.

PMID:
11077510
47.
48.
50.

[Vitamin E is beneficial for the immune system in the elderly].

Landmark K.

Tidsskr Nor Laegeforen. 1998 Nov 20;118(28):4403-4. Review. Norwegian. No abstract available.

PMID:
9889616

Supplemental Content

Loading ...
Support Center